Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
End-to-end platform for content validation and sales force readiness.
AI-powered congress engagement coordinator.
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
Join the Viseven team and grow your career with us
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Viseven is heading to Chicago for the No Code Days: Freedom to Create conference organized by Creatio. The free 2-day conference will connect hundreds of professionals. The event is dedicated to implementing no-code solutions for business units wired to the technical industries. The two-day conference will highlight the best practices for international digital business needs. […]
Can isolation and innovation work together? We proved; we can make it. As they say, however, two masterminds always act better, turning any challenge into balance. Thus, Next Pharma got us together again around the industry’s sharpest commercial event. On May 17-18, Dubrovnik turned into the center of decision-making on what is next for pharma. At […]
Modular content has been in the spotlight of many discussions in the pharma marketing community lately. Not only is it said to deliver the industry from chronic “ailments” like MLR hurdles, content production bottlenecks, and time-to-market anxieties – there are rumors this approach is capable of much more. Fueling omnichannel ambitions with personalized content […]
Veeva Summit once again proved that communication, in fact, is the language of leadership. On May 5, all life sciences industry leaders were invited to Boston to meet the lineup of the best industry experts in the pharma and tech fields. At 55+ sessions, they are about to share the latest findings, valuable insights and […]
Why is a raven like a writing desk? Who knows! However, we know exactly what is common between tech and art. Both are products of human imagination. Being the complicated area where many things come together and overlap, the content creation in pharma is a palette of different systems and tools mixed with the strategic work of […]
On every corner, we can hear success stories of pharma heavyweights, showing us the extraordinary level of personalization, they put into their strategies and win. But what are these stories are made of? Personalization introduces an extra ingredient, those that customers seek everywhere, and the one that eventually wins them over. Now, when the customers’ choices are especially […]
The state of constant search is the nature of the scientific community. Only the one who never stops is finding all-new easter eggs, discovering new scenes, and is blessed with the greatest discoveries. The lack of resilience and the search for truth is what made the pharma industry a hero of the day with all […]
Global pharma companies appear to hold all the cards in emerging markets — stronger R&D pipelines, higher digital maturity, and the resources to execute at scale. Yet drug accessibility rarely comes down to a single decision at corporate HQ. Behind every market entry lies a more complex reality: localization is not simply translation, and most […]
In pharma, broken processes have a long shelf life. Content workflows are no exception — teams notice the inefficiencies, the duplicated effort, the review cycles that drag on for too long, but the perceived risk of changing anything keeps them from acting on it. The result is a kind of institutional inertia: everyone sees the […]
Would you be okay starting a therapy with a 2.5-star rating for a condition where every moment impacts clinical outcomes? Now imagine coming across a negative patient review, or seeing a trusted HCP publicly question its effectiveness or highlight side effects. Even in oncology, where treatment decisions are guided by HCPs, what patients read online […]
